Cargando…
Response of metastatic mouse invasive lobular carcinoma to mTOR inhibition is partly mediated by the adaptive immune system
Effective treatment of invasive lobular carcinoma (ILC) of the breast is hampered by late detection, invasive growth, distant metastasis, and poor response to chemotherapy. Phosphoinositide 3-kinase (PI3K) signaling, one of the major druggable oncogenic signaling networks, is frequently activated in...
Autores principales: | Klarenbeek, Sjoerd, Doornebal, Chris W., Kas, Sjors M., Bonzanni, Nicola, Bhin, Jinhyuk, Braumuller, Tanya M., van der Heijden, Ingrid, Opdam, Mark, Schouten, Philip C., Kersten, Kelly, de Bruijn, Roebi, Zingg, Daniel, Yemelyanenko, Julia, Wessels, Lodewyk F.A., de Visser, Karin E., Jonkers, Jos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028325/ https://www.ncbi.nlm.nih.gov/pubmed/32117586 http://dx.doi.org/10.1080/2162402X.2020.1724049 |
Ejemplares similares
-
PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma
por: Boelens, Mirjam C., et al.
Publicado: (2016) -
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer
por: Bhin, Jinhyuk, et al.
Publicado: (2023) -
p120-Catenin Is Critical for the Development of Invasive Lobular Carcinoma in Mice
por: Tenhagen, Milou, et al.
Publicado: (2016) -
Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland
por: Annunziato, Stefano, et al.
Publicado: (2016) -
Identifying transposon insertions and their effects from RNA-sequencing data
por: de Ruiter, Julian R., et al.
Publicado: (2017)